HEMAJO financials
A multi-period view of the public annual-account figures reported for HEMAJO, with comparable measures and links to available source documents.
Company overviewRegistry number
0717934315
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for HEMAJO
2025 versus 2024
- Operating line
- €651,917
- EBITDA
- €157,253
- Total assets
- €746,858
- Equity
- €11,742
+41.1%
+298.5%
+22.6%
+116.4%
EBITDA margin +24.1% · Equity ratio +1.6%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €651,917 | €157,253 | €746,858 | €11,742 | - |
| 202431 Dec 2024 | €462,163 | €39,460 | €608,998 | -€71,514 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.